Brain pacemaker for Tourette's: 5-Year tracking study launches
NCT ID NCT04449068
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 20 adults with severe, drug-resistant Tourette syndrome who receive deep brain stimulation (DBS) targeting a specific brain region. Researchers will check tic severity, mental health, and quality of life every year for five years after surgery. The goal is to understand how well DBS controls symptoms over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOURETTE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CIC Neurosciences, GH Pitié-Salpêtrière
RECRUITINGParis, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A common antidepressant may tame anxiety in kids with autism and ADHD — a trial puts it to the test
- Brain scans may reveal why behavioral therapy helps some teens with tics
- Can a dopamine-blocking drug safely control tourette syndrome over years?
- Mapping tic patterns could lead to personalized therapy for tourette syndrome
- Sound waves aimed at the brain could quiet tics without surgery
- Wrist zap may tame tics: electrical pulses tested as Drug-Free option